All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Occult HBV Infection-38766475

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	38766475	A128V	S	S	Occult HBV Infection	G R C L	View
2	38766475	C121Y	S	S	Occult HBV Infection	G R C L	View
3	38766475	C124R	S	S	Occult HBV Infection	G R I C L	View
4	38766475	C138R	S	S	Occult HBV Infection	G R C L	View
5	38766475	C139W	S	S	Occult HBV Infection	G R C L	View
6	38766475	C147R	S	S	Occult HBV Infection	G R I C L	View
7	38766475	C147Y	S	S	Occult HBV Infection	G R I C L	View
8	38766475	C149R	S	S	Occult HBV Infection	G R C L	View
9	38766475	D144G	S	S	Occult HBV Infection	G R C L	View
10	38766475	F158L	S	S	Occult HBV Infection	G R C L	View
11	38766475	F158Y	S	S	Occult HBV Infection	G R C L	View
12	38766475	G130V	S	S	Occult HBV Infection	G R C L	View
13	38766475	I110L	S	S	Occult HBV Infection	G R C L	View
14	38766475	I110V	S	S	Occult HBV Infection	G R C L	View
15	38766475	I126T	S	S	Occult HBV Infection	G R I C L	View
16	38766475	I126V	S	S	Occult HBV Infection	G R C L	View
17	38766475	I152T	S	S	Occult HBV Infection	G R C L	View
18	38766475	I152V	S	S	Occult HBV Infection	G R C L	View
19	38766475	K122E	S	S	Occult HBV Infection	G R I C L	View
20	38766475	K141R	S	S	Occult HBV Infection	G R C L	View
21	38766475	L104S	S	S	Occult HBV Infection	G R C L	View
22	38766475	L109P	S	S	Occult HBV Infection	G R C L	View
23	38766475	L162R	S	S	Occult HBV Infection	G R C L	View
24	38766475	M133I	S	S	Occult HBV Infection	G R C L	View
25	38766475	M133L	S	S	Occult HBV Infection	G R I C L	View
26	38766475	M133T	S	S	Occult HBV Infection	G R I C L	View
27	38766475	N146S	S	S	Occult HBV Infection	G R C L	View
28	38766475	P111L	S	S	Occult HBV Infection	G R C L	View
29	38766475	P120S	S	S	Occult HBV Infection	G R C L	View
30	38766475	P127T	S	S	Occult HBV Infection	G R C L	View
31	38766475	P151H	S	S	Occult HBV Infection	G R C L	View
32	38766475	P151L	S	S	Occult HBV Infection	G R C L	View
33	38766475	S113T	S	S	Occult HBV Infection	G R C L	View
34	38766475	S114P	S	S	Occult HBV Infection	G R C L	View
35	38766475	T118I	S	S	Occult HBV Infection	G R C L	View
36	38766475	T126A	S	S	Occult HBV Infection	G R I C L	View
37	38766475	T131A	S	S	Occult HBV Infection	G R C L	View
38	38766475	T131S	S	S	Occult HBV Infection	G R C L	View
39	38766475	T140S	S	S	Occult HBV Infection	G R C L	View
40	38766475	T143S	S	S	Occult HBV Infection	G R C L	View
41	38766475	T148A	S	S	Occult HBV Infection	G R C L	View
42	38766475	V106G	S	S	Occult HBV Infection	G R C L	View
43	38766475	V168D	S	S	Occult HBV Infection	G R C L	View
44	38766475	W163R	S	S	Occult HBV Infection	G R C L	View
45	38766475	W163X	S	S	Occult HBV Infection	G R C L	View
46	38766475	Y100C	S	S	Occult HBV Infection	G R C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.